PMC:7172841 / 553-710 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T3","span":{"begin":11,"end":14},"obj":"Body_part"},{"id":"T4","span":{"begin":71,"end":82},"obj":"Body_part"},{"id":"T5","span":{"begin":89,"end":100},"obj":"Body_part"},{"id":"T6","span":{"begin":126,"end":131},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma84795"},{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma62863"},{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma62863"},{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"D related (HLA-DR) expression accompanied by profound depletion of CD4 lymphocytes, CD19 lymphocytes, and natural killer (NK) cells. Tumor necrosis factor-α "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T10","span":{"begin":133,"end":138},"obj":"Disease"}],"attributes":[{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"}],"text":"D related (HLA-DR) expression accompanied by profound depletion of CD4 lymphocytes, CD19 lymphocytes, and natural killer (NK) cells. Tumor necrosis factor-α "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T4","span":{"begin":67,"end":70},"obj":"http://purl.obolibrary.org/obo/PR_000001004"},{"id":"T5","span":{"begin":84,"end":88},"obj":"http://purl.obolibrary.org/obo/CLO_0053432"},{"id":"T6","span":{"begin":121,"end":131},"obj":"http://purl.obolibrary.org/obo/CL_0000623"}],"text":"D related (HLA-DR) expression accompanied by profound depletion of CD4 lymphocytes, CD19 lymphocytes, and natural killer (NK) cells. Tumor necrosis factor-α "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T2","span":{"begin":15,"end":17},"obj":"Chemical"}],"attributes":[{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_73445"}],"text":"D related (HLA-DR) expression accompanied by profound depletion of CD4 lymphocytes, CD19 lymphocytes, and natural killer (NK) cells. Tumor necrosis factor-α "}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T4","span":{"begin":139,"end":147},"obj":"http://purl.obolibrary.org/obo/GO_0070265"},{"id":"T5","span":{"begin":139,"end":147},"obj":"http://purl.obolibrary.org/obo/GO_0019835"},{"id":"T6","span":{"begin":139,"end":147},"obj":"http://purl.obolibrary.org/obo/GO_0008219"},{"id":"T7","span":{"begin":139,"end":147},"obj":"http://purl.obolibrary.org/obo/GO_0001906"}],"text":"D related (HLA-DR) expression accompanied by profound depletion of CD4 lymphocytes, CD19 lymphocytes, and natural killer (NK) cells. Tumor necrosis factor-α "}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T4","span":{"begin":133,"end":138},"obj":"Phenotype"}],"attributes":[{"id":"A4","pred":"hp_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"D related (HLA-DR) expression accompanied by profound depletion of CD4 lymphocytes, CD19 lymphocytes, and natural killer (NK) cells. Tumor necrosis factor-α "}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T15","span":{"begin":11,"end":14},"obj":"PR:000029150"},{"id":"T16","span":{"begin":19,"end":29},"obj":"GO:0010467"},{"id":"T17","span":{"begin":67,"end":70},"obj":"PR:000001004"},{"id":"T18","span":{"begin":71,"end":82},"obj":"CL:0000542"},{"id":"T19","span":{"begin":84,"end":88},"obj":"PR:000001002"},{"id":"T20","span":{"begin":89,"end":100},"obj":"CL:0000542"},{"id":"T21","span":{"begin":106,"end":120},"obj":"CL:0000623"},{"id":"T22","span":{"begin":133,"end":156},"obj":"PR:000000134"},{"id":"T58214","span":{"begin":11,"end":14},"obj":"PR:000029150"},{"id":"T41859","span":{"begin":19,"end":29},"obj":"GO:0010467"},{"id":"T17537","span":{"begin":67,"end":70},"obj":"PR:000001004"},{"id":"T14494","span":{"begin":71,"end":82},"obj":"CL:0000542"},{"id":"T5373","span":{"begin":84,"end":88},"obj":"PR:000001002"},{"id":"T95317","span":{"begin":89,"end":100},"obj":"CL:0000542"},{"id":"T66709","span":{"begin":106,"end":120},"obj":"CL:0000623"},{"id":"T65169","span":{"begin":133,"end":156},"obj":"PR:000000134"}],"text":"D related (HLA-DR) expression accompanied by profound depletion of CD4 lymphocytes, CD19 lymphocytes, and natural killer (NK) cells. Tumor necrosis factor-α "}

{"project":"LitCovid-PubTator","denotations":[{"id":"36","span":{"begin":67,"end":70},"obj":"Gene"},{"id":"37","span":{"begin":84,"end":88},"obj":"Gene"},{"id":"38","span":{"begin":133,"end":156},"obj":"Gene"}],"attributes":[{"id":"A36","pred":"tao:has_database_id","subj":"36","obj":"Gene:920"},{"id":"A37","pred":"tao:has_database_id","subj":"37","obj":"Gene:930"},{"id":"A38","pred":"tao:has_database_id","subj":"38","obj":"Gene:7124"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"D related (HLA-DR) expression accompanied by profound depletion of CD4 lymphocytes, CD19 lymphocytes, and natural killer (NK) cells. Tumor necrosis factor-α "}